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Abstract 
The successful fabrication of hydroxyapatite-bioactive glass scaffolds using honeycomb 
extrusion is presented herein. Hydroxyapatite was combined with either 10 wt% stoichiometric 
Bioglass® (BG1), calcium-excess Bioglass® (BG2) or canasite (CAN). For all composite 
materials, glass-induced partial phase transformation of the HA into the mechanically weaker 
ȕ-tricalcium phosphate (TCP) occurred but XRD data demonstrated that BG2 exhibited a lower 
volume fraction of TCP than BG1. Consequently, the maximum compressive strength observed 
for BG1 and BG2 were 30.3 r 3.9 and 56.7 r 6.9 MPa, respectively, for specimens sintered at 
1300 °C. CAN scaffolds, in contrast, collapsed when handled when sintered below 1300 °C, 
and thus failed. The microstructure illustrated a morphology similar to that of BG1 sintered at 
1200 °C, and hence a comparable compressive strength (11.4 r 3.1 MPa). The results highlight 
the great potential offered by honeycomb extrusion for fabricating high-strength porous 
scaffolds. The compressive strengths exceed that of commercial scaffolds, and biological tests 
revealed an increase in cell viability over seven days for all hybrid scaffolds. Thus it is expected 
that the incorporation of 10 wt% bioactive glass will provide the added advantage of enhanced 
bioactivity in concert with improved mechanical stability. 
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1 Introduction 
Porous synthetic bone scaffolds continue to be a subject of great interest. These are used in the 
treatment of orthopaedic abnormalities, and can be derived either naturally (autograft, allograft 
or xenograft) or synthetically1. Traditionally, autografts and allografts are used, but these are 
associated with disease transmission, poor histocompatibility, limited availability and high 
costs2-4. Synthetic bone graft substitutes (BGS) overcome the aforementioned complications, 
and hence, have been extensively studied over the past few decades. In addition, there are 
several synthetic materials that possess bioresorbable properties that preclude the need for a 
second operation, thereby halving surgery-associated risks5. 
 The ideal BGS should be bioactive, porous and mechanically sound6, 7. Ceramic 
honeycomb extrusion is a technique capable of achieving porous ceramic BGS with 
compressive strengths comparable to that of cortical bone8, which has seldom been achieved 
by both traditional and contemporary fabrication techniques used to fabricate BGS. In addition, 
honeycomb extrusion is unique in that it offers controlled and interconnected porosity, 
fabrication of large-sized scaffolds and is industrially scalable9, 10. In spite of these 
advantageous, the technique has not been widely adopted for BGS. As such, honeycomb 
extrusion has only been used to fabricate hydroxyapatite (HA)8 or ȕ-tricalcium phosphate (ȕ-
TCP)10. Although honeycomb extrusion was successful in fabricating these materials with 
mechanical properties exceeding that of traditional methods (i.e. > 20 MPa), their respective 
biological properties were not optimized. 
 ,Q OLJKW RI +$¶V biological limitation, the state of the art in scaffold fabrication 
encompasses a multi-material approach, with emphasis on hybridising materials from different 
classes. The aim therein is to deliver a BGS that overcomes undesirable biological behaviour 
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of calcium phosphates. A common hybridising approach is to combine HA or ȕ-TCP with 45S5 
Bioglass® (BG)11, 12, which is amongst the most widely researched and clinically used 
biomaterials. BG possesses exceptional bioactivity, and indeed its addition to HA and ȕ-TCP 
has been shown to improve bioactivity11, 12. This was attributed to the chemical composition of 
BG, whereby the dissolution of ions elicits a response that results in bioactivity within minutes 
of in vivo implantation. Furthermore, the addition of bioactive glasses have been demonstrated 
to improve the compressive strengths of HA. This is achieved through liquid-phase sintering, 
whereby the glass melts and through capillary forces and particle rearrangement, enhances the 
densification of HA13-16. Therefore, the rationale for incorporating glass is to enhance both the 
biological and mechanical properties. 
 Glasses containing CaO-P2O5 are generally considered as bioactive because of their 
analogous elemental composition to the inorganic component of bone17. Canasite (CAN) is one 
such example. In its glass-ceramic form, canasite demonstrates exceptional mechanical 
properties in comparison to BG18, 19. Furthermore, canasite contains fluorine and potassium that 
are prevalent as trace ions in bone20, but are not found in 45S5 BG. Moreover, the fluorine 
results in a fluorapatite layer forming in vivo that is more chemically stable than a 
hydroxyapatite layer observed in BG11. Despite these exceptional properties, the material has 
not been studied as a hybrid with HA.  
 The current study progresses the application of honeycomb extrusion by demonstrating 
its versatility for the fabrication of porous ceramic-glass hybrid materials by combining HA 
with three bioactive glasses: either stoichiometric BG, calcium-excess BG or canasite. The 
hybrid scaffolds were then shaped and sintered at 1200, 1250 and/or 1300 °C, and subsequently 
characterized for their chemical, physical and biological properties. 
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2  Experimental Procedure  
2.1  Raw Materials 
Hydroxyapatite powder (Purum grade, Sigma Aldrich, UK) was produced by calcining at 1000 
°C for five hours prior to mixing. The bioactive glasses were prepared using the melt-quenching 
technique. All precursor reagents were purchased from Glassworks Services (Doncaster, UK) 
except the calcium fluoride (analytical grade, Fisher Scientific, UK) and the ammonium 
dihydrogen phosphate (analytical grade, Acros Organics, UK). Before melting the precursors, 
the powders were dried overnight in an oven, and then mixed using the high-shear energy mixer 
for homogenisation and de-agglomeration. Batches of 250 g were melted in a mullite crucible 
at 1450 °C in air for 4 hours. The melt was quenched in distilled water and casted as frit. The 
frit was then crushed and ground into fine glass powder using an in-house percussion mortar, 
planetary mill (Fritsch, Germany) and an attrition mill (Union Process®, USA). Table 1 
enumerates the oxide composition used for all three glasses. 
2.2 Fabrication Process 
Clay-OLNHSDVWHVZHUHIRUPXODWHGXVLQJ0HWKRFHO(Trademark of Dow Chemical Company, 
USA) and distilled water as additives. Initially, the HA and bioactive glass powders were mixed 
together using the high-shear energy mixer for ten minutes 6SHHGPL[HU DAC 300 FVZ, 
Synergy Devices, UK). The binder was added thereafter and mixed for a further five minutes. 
Lastly, distilled water was added, wherein mixing continued until an extrudable paste was 
formulated. Table 2 lists the paste composition used for all samples.  
Porous scaffolds were fabricated using an in-house extruder and honeycomb die. The 
extruder die geometry and extrusion speed have been previously reported in Ref21. Prior to 
extrusion, the pastes were vacuumed and compacted in situ. A servo-hydraulic press was used 
to actuate the piston using a controller (SmarTest ONE, MOOG, USA). Once extruded, the 
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green bodies were allowed to dry overnight before transferred to a muffle furnace (Elite 
Thermal Systems Ltd, UK) for de-binding and sintering. De-binding was performed at 1 °C/min 
to a maximum temperature of 400 °C. A multi-stage temperature procedure was used to sinter 
the extrudates. First, the extrudates were sintered at 5 °C/min until 600 °C, followed by a 
heating rate of 1 °C/min until 800 °C after which a dwell of one hour was applied, before 
ramping to either 1200, 1250 or 1300 °C at a rate of 5 °C/min followed by a dwell period of 
eight hours, and a cooling rate of 2.5 °C/min. The extrudates were then sectioned into 4.1 x 4.1 
x 4.5 cm3 scaffolds for optical analysis, and quantitative measurements of bulk porosity and 
compressive strength.  
2.3 Characterisation 
2.3.1 Particle Characterisation 
The bioactive glass powders were characterized for their density, surface area and particle size. 
Powder density measurements were performed using a helium pycnometer (Accupyc 1340, 
Micromeritics, UK). A multipoint BET Surface analysis was performed using a surface 
characterizer (3Flex, Micromeritics, UK); and the results were inspected for evidence of 
experimental errors as detailed in Ref. 22. Particle size analysis was conducted using a particle 
size analyzer (Mastersizer 3000, Malvern, UK), where all samples were subjected to vigorous 
ultrasound prior to measurements. In addition, simultaneous thermal analysis (STA) (SDT-
Q6000, TA Instruments, UK) was employed to elucidate the thermal characteristics of the raw 
powders. The thermal behaviour of the bioactive glass is key to defining a sintering profile for 
the hybrid extrudates. Samples were poured into an alumina pan, and analysed in air with a 
flow rate of 100 ml/min. 
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2.3.2 Chemical Analyses 
Powdered samples were characterized using X-ray fluorescence (XRF) (Zetium, Panalytical, 
UK), X-ray diffraction (XRD) (D5000, Siemens, UK) and Fourier-transformation-infrared 
spectroscopy (FTIR) (Frontier, Perkin Elmer, UK). For FTIR, samples were ground with 
potassium bromide and pressed into disks, using a stainless steel die, prior to analysis at a ratio 
of 2:200 mg. For chemical analyses of sintered scaffolds, samples were ground crushed and 
ground into fine powder, and thoroughly mixed. 
2.3.3 Microscopy 
Scanning electron microscopy (SEM) (Inspect F50, FEI, USA) was used to observe the 
microstructural features on gold-coated samples. Optical microscopy (BA310Met-T, Miotic) 
was also employed to examine macro-pore size and strut thickness. 
2.3.4 Scaffold Characterisation 
The scaffolds were characterized with respect to their chemical properties using XRD and 
FTIR, as detailed in 2.3.2. The scaffolds were ground into fine powder using first a stainless 
steel percussion mortar, followed by an agate pestle and mortar prior to analysis. Scaffold bulk 
porosity was measured using the helium pycnometer described in 2.3.1. The protocol used and 
the derived porosity calculation has been previously detailed23. Compression tests were carried-
out using a universal testing machine (Roell, Zwick, UK) fitted with a 20 kN load cell (Xforce 
K, Zwick; 0.5% resolution) at a rate of 1 mm/min. Compression loading was performed parallel 
to the cell alignment. 
2.3.5 Cell Viability 
Cell viability tests were performed on discoid pellets of the hybrid materials. Samples were 
prepared using a stainless steel die press, and subsequently sintered in muffle furnace. Once 
sintered, the samples were then autoclaved at a temperature of 121 °C for thirty minutes prior 
to commencing the cell viability. The protocol can be found in the Appendix 1.  
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3 Results and Discussion 
3.1 Raw Material Properties 
The aim of the comminution procedure was to attain particle sizes below 100 µm. This would 
ensure that the glass particles can traverse the narrowest gap within the honeycomb die (500 
µm). Furthermore, smaller particle sizes would ensure better dispersion of glass particles within 
the HA powders, and consequently mitigate heterogeneous densification. Moreover, this has to 
be achieved without significant contamination from the milling media. The following section 
details the raw glass powder properties with regards to particle, chemical and thermal 
properties.  
3.1.1 Powder Properties 
Powder properties are known to affect the final scaffold properties, and thus, it is necessary to 
note the powder characteristics. Table 3 enumerates the particle properties with regards to size, 
density and surface area. As demonstrated, the comminution approach used was successful in 
reducing the particle sizes to below 100 µm. In doing so, the powder densities varied from 2.63 
to 2.75 g/cm3, similar to those previously reported for BG24. Furthermore, the surface area 
ranged from 2.25 to 3.57 m2/g. Fig. 1 portrays the morphology of the glass particles following 
comminution.  
3.1.2 Chemical Properties 
X-ray Fluorescence (XRF) was used to detect the elemental composition of the powders once 
ground, where calcium, sodium, silicon, phosphor and aluminium were detected; and fluoride 
and potassium for canasite glass. XRF of the milled glass powders revealed minor 
compositional changes during glass melting, wherein dissolution of aluminium from the 
crucible had occurred. However, no compositional variation was observed due to milling. XRD 
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analysis of the raw glass powders was also conducted, and the results are presented in Fig. 2. 
All samples displayed an amorphous hump and no crystalline phases.  
 Fig. 3 depicts the FTIR results of the raw powders. The BG samples displayed similar 
spectra, with silica bands detected at 1035, 930, 745, 502 cm-1; and a phosphate band at 605 
cm-1. Silica bands in the canasite were detected at 1040, 777 and 470 cm-1, and a phosphate 
band between 606-575 cm-1. Therefore, FTIR analyses corroborated with the XRD in 
demonstrating the absence of crystallinity in all glass powders.  
3.1.3 Thermal Properties 
Simultaneous thermal analysis (STA) was employed to determine the melting points for the 
glasses in order to achieve liquid-phase sintering. Fig. 4 outlines the STA thermograms, which 
comprised differential scanning calorimetry (DSC) and thermal gravimetric analysis (TGA). 
Melting of the glass manifested in the form of a sharp endothermic peak at approximately 1200 
°C in DSC. Furthermore, a transient mass loss was observed that coincided with the DSC 
endotherm, which was attributed to the loss of phosphate in all samples25 and silicon 
tetrafluoride in CAN25, 26 during melting. TGA also determined that the final mass loss was <2 
wt%, which was attributed to said volatiles and dehydration.  
 The STA data revealed the melting points of BG1, BG2 and CAN, which were 1158, 
1183 and 1230 °C, respectively. The difference in melting properties of BG1 and BG2 were 
due to the latter possessing less sodium oxide concentration, which is a known fluxing agent 
used to reduce the melting temperature of glass networks27. The reduction thereof in BG2 thus 
mitigated the fluxing effect. Therefore, the substitution of 5 wt% CaO for Na2O resulted in a 
more thermally stable material. From the STA data, it was decided that BG1 and BG2 hybrids 
would be sintered at 1200, 1250 and 1300 °C to obtain liquid phase sintering; whereas CAN 
hybrids would be sintered at 1250 and 1300 °C as melting commenced above 1200 °C. 
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In summary, crystalline-free Bioglass® and Canasite powders were successfully 
synthesized using the melt-quenching approach, and subsequently ground. The comminution 
steps resulted in particle sizes suitable for extrusion without producing significant 
contamination. STA data revealed that BG2 was more thermally stable than BG1, however both 
melted at <1200 °C. Canasite on the other hand exhibited the highest melting temperature, 
which precluded it from being sintered at 1200 oC.  
 
3.2 Scaffold Properties 
HA scaffolds with 10 wt% glass were successfully extruded, and sintered at different 
temperatures. Canasite samples sintered at 1250 oC cracked when handled. Hence, only the 
complete data of the CAN samples sintered at 1300 oC are reported. Fig. 5 are various images 
of the fashioned CAN sample. 
3.2.1 Chemical Structure 
3.2.1.1 XRD 
XRD analyses of sintered scaffolds are illustrated in Fig. 6 and Fig. 7. All samples exhibited a 
biphasic calcium phosphate (CaP) composition comprising ȕ-tricalcium phosphate (ȕ-TCP) 
(PDF: 04-001-7104) and HA (PDF: 01-089-4405). In addition, traces of calcium silicate 
(CaSiO3) (PDF: 04-010-0710) were detected.  
In BG1, ȕ-TCP peaks were more dominant than HA, and remained so in samples 
sintered at 1300 °C, but their dominance gradually diminished with increasing sintering 
temperature. As Fig. 6(b) illustrates, the large peaks pertaining to ȕ-TCP and HA at 31 and 
31.6°, respectively, were comparable in intensity. BG2, in contrast, exhibited comparable ȕ-
TCP and HA peak intensities when sintered at 1200 °C, with the HA phases dominating when 
sintered at 1250 and 1300 °C (Fig. 6(a)). Furthermore, BG2 exhibited more intense peaks 
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associated with a CaSiO3 phase which increased in intensity with increasing sintering 
temperature.  
 Fig. 7 depicts the XRD pattern of canasite hybrid scaffolds sintered at 1250 and 1300 
°C. The results are akin to BG1, wherein the ȕ-TCP dominated over HA, and traces of CaSiO3 
(CS) were observed. As mentioned, scaffolds sintered at 1250 °C fractured when handled, 
however the XRD data was included to highlight the reduction in ȕ-TCP phase with increasing 
temperature, which is again mirrored by increases to HA and CaSiO3 peaks.  
Phase transformation of HA in the presence of bioactive glass into ȕ-TCP have been 
previously documented28-31. HA is known to decompose into anhydrous calcium phosphate 
phases at elevated temperatures32, however, this was not believed to be the case herein. On the 
contrary, increasing the sintering temperature favoured HA phase formation. Thus, it was 
concluded that the addition of glass induced the phase transformation, as opposed to a 
temperature-induced phase transformation.  
The bioactive glass-induced phase transformation can be ascribed to the imbalance in 
calcium concentration between HA and glass; whereby a concentration gradient was 
established across the two phases. Calcium, in the form of calcium oxide, diffused from the 
hydroxyapatite into the glassy phase, which is relatively deficient in calcium. The following 
established reaction33 was proposed: 
Ca10(PO4)6(OH)2 ื 3Ca3(PO4)2 + CaO + H2O 
In addition, the calcium oxide could further react with the phosphate and silica group from the 
glass to yield more ȕ-TCP and calcium silicate, respectively: 
4CaO + (45SiO2Â&D2Â1D22Â32O5) ื Ca3(PO4)2 +CaSiO3 
+ (44SiO2Â&D2Â1D22ÂP2O5) 
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This reaction also explains why hybrids containing BG2 exhibited a lower concentration of 
TCP. BG2, with a higher CaO concentration than BG1 and CAN, alleviated the diffusion 
gradient and hence reduced the driving force for Ca2+ to migrate from the HA. Therefore, it can 
be concluded that increasing the calcium oxide quantity in a glass will mitigate the phase 
transformation to TCP in HA-bioactive glass hybrids. Moreover, decreasing the surface area 
by sintering at higher temperatures may also reduce the interfacial region over which the 
calcium can migrate from the HA. This could explain why with increasing sintering temperature 
a decrease in ȕ-TCP intensity was observed. This behaviour has been previously noted by other 
researchers15, 29.  
3.2.1.2 FTIR 
FTIR analysis of the hybrid samples are outlined in Fig. 8 and Fig. 9, wherein functional groups 
pertaining to ȕ-TCP and HA were detected. In BG1 and BG2, phosphate bands pertaining to ȕ-
TCP were observed at 1120, 1080, 1043, 945, 604 and 553 cm-134, 35; whereas those associated 
with HA were detected at 1010, 980, 590 and 565 cm-1; a hydroxyl group indicative of HA was 
detected at 3570 cm-1 in 1200 and 1250 °C36.  
 FTIR analyses of CAN-HA only detected phosphate bands of ȕ-TCP, and a hydroxyl 
group at 3530 cm-1.  Phosphates associated with HA and ȕ-TCP share similar band positions, 
and in concert with a relatively poorly defined spectra, made it difficult to discern between the 
two. XRD analyses of HA-CAN highlighted tKDWȕ-TCP was the more dominant phase, and 
hence the bands ascribed to this phase. 
3.2.2 Physical and Mechanical Properties 
Optical microscopy was utilized to determine the macro-pore size achieved (i.e. the extruded 
channels). These ranged from 750-940 µm, which are greater than the desirable sizes for 
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scaffolds37, thus providing enhanced  nutrient transport and cell attachment for facilitating bone 
ingrowth 38.  
Fig. 10 (a) depicts the bulk porosity values for all the samples, which is the total porous 
volume of the scaffolds. The volume porosity of BG1 scaffolds sintered at 1200 oC was 71.6 r 
1.11 vol%, which decreased to 61.8 r 0.9 and 59.6 r 1.0 vol% when the sintering temperature 
was raised to 1250 and 1300 oC, respectively. Bulk porosity values for BG2 scaffolds were 
generally lower than their BG1 equivalent, with values of 61.9 r 0.7, 57.1 r 1.3 and 55.0 r 0.6 
vol% obtained for scaffolds sintered at 1200, 1250 and 1300 oC, respectively. The canasite 
scaffolds sintered at 1300 oC possessed a bulk porosity of 62.3 r 0.8 vol%.  
3.2.3 Microstructure 
Following compression testing, the microstructure of fractured hybrid scaffolds were 
investigated using SEM (Fig. 11 and Fig. 12). The mode of fracturing was mixed in all samples, 
consisting of both inter- and transgranular fractures. Furthermore, a highly micro-porous 
morphology was descried, with pore sizes of < 10 µm, which can facilitate protein adsorption39, 
40
. The micrographs revealed small sintering necks had formed between adjacent HA grains in 
the BG samples sintered at 1200 °C. The morphology presented with an appearance that is 
similar to the initial stage of sintering41, despite using high temperatures. Increasing the 
sintering temperatures to 1250 and 1300 °C proceeded to densify the scaffolds, however, 
complete densification was not attained, as previously achieved by the author23. Nevertheless, 
it was evident that the improved compressive strengths with increasing sintering temperature 
was a reflection of the microstructural densification. 
The CAN scaffolds sintered at 1300 °C presented with similar neck sizes to that of BG1 
sintered at 1200 °C, which explains why hybrids thereof possessed the weakest compressive 
strength in all samples sintered at 1300 °C. Thus it could be inferred the scaffolds sintered 
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below 1300 °C did not coalesce. This could also be the reason why the HA-CAN samples 
sintered at 1250 °C failed. Further experiments will need to be conducted to elucidate the cause 
of the poor densification of HA and CAN in comparison to BG15.  
Santos et al. (1994) investigated both CaO-P2O5 binary glass systems and BG29. In 
contrast to CaO-P2O5 binary glass, the authors reported an increase in TCP phase with the 
incorporation of BG, and surmised the presence of sodium in BG expedited hydroxyapatite 
decomposition, and hence hindered densification. This is in agreement with the present study, 
whereby a decrease in Na content increased densification. Bellucci et al. (2013) compared the 
40 wt% addition of both CaO-excess and stoichiometric BG. The authors reported the latter, 
which possessed a markedly higher Na content, to result in a greater densification when sintered 
at 1150 °C42. Hence, the effects of Na may differ depending on the ratio of HA to BG. 
0RUHRYHUWKHVXEVWLWXWLRQRI6LLQWR+$PD\KDYHDOVRLQIOXHQFHGWKHODWWHU¶VGHQVLILFDWLRQDV
Si has been revealed to lower the sintered density of HA43, 44. Therefore, it can be reasoned that 
reducing either Si and/or Na in BG will enhance densification of HA-BG hybrids. However, 
the inclusion of both Na are Si are required for achieving desirable biological properties. Thus, 
said consequences must be considered during the design process. 
 One approach in reducing the effects of Si- or Na-induced decomposition is to decrease 
the proportion of bioactive glass content within the composite. Indeed, previous studies have 
shown small quantities of CaO-P2O5 binary glass yielded enhanced densification relative to 
pure HA. However, Tancred et al. (2001) investigated the addition of BG content ranging from 
2.5 to 50 wt% and reported a decrease in densification compared to pure HA, with further 
decreases observed at higher glass content45. Furthermore, Knowles et al. (1996) also observed 
a decrease in densification with the addition of 2 wt% Na2O-CaO-P2O5 glass15. Thus, 
decreasing the BG content in this study may have provided no benefits to densification. 
14 
 
From Table 5, it is evident that a longer dwell time was used in the present study in 
comparison to previous work. An extended dwell time was expected to provide sufficient time 
for the glass melt to wet the ceramic particles and achieve liquid phase sintering. This was not 
attained herein, and hence it can be concluded that a long dwell time provided no benefits. On 
the other hand, an increase in densification with increasing temperature was achieved, which is 
in agreement with previous studies that reported similar trends13, 15, 29. Increase in temperature 
progresses ceramic densification, however, it can also increase glass reactivity, which 
suppresses densification. As mentioned in section 3.2.1.1, it is possible that the HA particles 
achieved a higher degree of sintering at increasing temperatures, thereby reducing the 
interfacial area prior to glass melt wetting and, hence, reducing the rate of decomposition. 
Knowles et al. (1996) observed increases in density with increasing temperature until 1350 °C, 
ZKHUHDWVLJQLILFDQWȕ-TCP lead to expansion in the material. Therefore, increasing sintering 
temperature is one method of achieving greater densification, provided the threshold for 
thermal-induced HA decomposition is not exceeded.   
 
3.2.4 Mechanical Properties 
Fig. 10 (b) depicts the corresponding maximum compressive strength values attained for the 
hybrid scaffolds when the load was applied parallel to the cell direction. The results illustrated 
that BG1 samples achieved values of 9.8 r 1.7, 24.1 r 3.3 and 30.3 r 3.9 MPa when processed 
at 1200, 1250 and 1300 oC, respectively; whereas, BG2 samples achieved 16.7 r 1.1, 48.4 r 
5.2 and 56.7 r 6.9 MPa, at identical sintering temperatures. Sintering the canasite scaffold at 
1300 oC resulted in a value of 11.4 r 3.1 MPa, which was considerably lower than either BG 
samples.  
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 Ceramic honeycomb extrusion has been demonstrated to produce porous scaffolds with 
remarkable compressive strengths46, and the present study provides further credence thereto. 
The compressive strengths recorded herein are considerably greater than pure HA scaffolds that 
are commercially available, such as the BGS Endobon®47. Furthermore, the addition of 10 wt% 
bioactive glass will expedite the slow bioactivity of HA. Therefore, taking these facets into 
consideration, the hybrid scaffolds fabricated herein are an excellent alternative to Endobon®. 
Moreover, the compressive strengths are exceptional given that they are comparable to that 
attained for dense HA-bioactive glass13, 48, 49. With regards to commercial hybrid BGS, the 
results are once more favourable. Bonelike®, which is a promising material that displays 
enhanced bioactivity with regards to standard HA, is composed of HA reinforced with 4 wt% 
bioactive glass, and is suitable for direct clinical use11. This was confirmed when Bonelike® 
was implanted in the tibia of 13 patients during osteotomy surgery, with the aim of treating the 
medial compartment osteoarthritis of the knee50. Though the porosity values are similar, 
hitherto the compressive strengths reported for Bonelike® are 2 MPa with pore sizes of 
approximately 100 µm51. Therefore, comprised of a higher glass composition and remarkably 
greater compressive strengths, it can be concluded that honeycomb extruded hybrid scaffolds 
used for similar clinical applications will result in superior biological and mechanical 
performances.  
It should be remarked that the compressive strengths obtained herein were lower than 
what has been obtained for pure HA scaffolds by extrusion46, 52. This decrease was attributed 
to the presence of ȕ-TCP, where the addition thereof to HA has been reported to mechanically 
weaken scaffolds53, 54. The current study adds further credence to this by illustrating that a 
bioactive glass composition capable of suppressing phase transformation of HA yielded higher 
compressive strengths, as observed in the HA-BG2 hybrid. In addition, BG2 exhibited 
relatively higher calcium silicate peaks, which has been previously reported to enhance the 
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compressive strength of HA scaffolds55, 56. Similarly, Desogus et al. (2015)57 found that CaO-
rich Bioglass® improved the mechanical properties of dense hybrids compared to 
stoichiometric BG, with higher Vickers hardness and elastic modulus recorded. Therefore, it 
can be inferred that increasing the CaO ratio improves the mechanical properties of hybrid 
scaffolds. 
Despite a decrease in compression strength with the hybrid scaffolds compared to pure 
HA scaffolds fabricated by ceramic honeycomb extrusion, the values remain considerably 
higher than that achieved by traditional fabrication methods, such as direct foaming58, polymer 
replication59 and sacrificial templating60. The enhanced strengths were attributed to an aligned 
porous architecture. Other fabrication methods of producing scaffolds with aligned porosity, 
which resulted in high strength scaffolds, are available, and examples are given in Table 4. 
Hence, there are alternatives to using ceramic extrusion for fabricating BGS. However, ceramic 
honeycomb extrusion offers speed, low capital and running cost, low skill requirement, and 
flexibility of altering pore geometry that make it an indispensable fabrication technique9. 
Ceramic extrusion has been revealed to produce high-strength scaffolds, as 
demonstrated by both honeycomb and co-extrusion approaches (Table 4). The latter 
encompasses the use of additives, such as camphene, to generate macro-pores. A previous study 
demonstrated that co-extrusion can produce HA scaffolds with higher compressive strength 
than honeycomb extrusion61, however, at a comparable porosity of 55 vol%62, the strength was 
markedly lower (Table 4). Thus with respect to achieving a balance between scaffold strength 
and porosity, honeycomb extrusion is more favourable. With regards to the fabrication process, 
honeycomb extrusion is once more advantageous. Co-extrusion relies on pore-forming 
additives to be in their molten state for formulating the ceramic feed. In the case of camphene 
the feed was processed at 60 °C62, and in another study, 105 °C61 was used. Whereas in 
honeycomb extrusion ceramic paste formulation, and extrusion thereafter, were performed at 
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room temperature, thereby obviating the need for high temperatures, and the costs associated 
therewith. Furthermore, honeycomb ceramic extrusion offers the simplicity of controlling pore 
geometry by altering die geometry. Roohani-Esfahani et al. (2016)63 demonstrated via 
robocasting that scaffolds with hexagonal pore geometry yielded the highest compressive 
strength. A die forming hexagonal pores can be readily manufactured, whereas in co-extrusion 
the molecular dynamics of, for example, liquid camphene will determine pore geometry. This 
will require considerable expertise to accomplish. 
Unidirectional freeze-casting is another technique capable of achieving high-strength 
HA scaffolds, as demonstrated by Deville et al. (2006)64. In comparison to their approach, 
honeycomb extrusion is considerably faster, as the process of generating green bodies in the 
latter is instantaneous; whereas in freeze casting time is needed for freezing the liquid phase. 
In addition, a sublimation stage is required for generating the pores, which further prolongs the 
fabrication process with respect to honeycomb extrusion. Furthermore, the preclusion of sub-
zero temperature requirements ensures honeycomb extrusion remains comparatively 
economically viable. Freeze casting has several other limitations that will need to be overcome 
before scaling up the process65, whereas extrusion has been successfully scaled-up for many 
decades, mainly in the automotive industry. At comparable porosity, Deville et al. (2006) 
attained a compressive strength of 65 MPa, which is greater than that reported in this study. 
However, the hybrid scaffolds formed herein comprised of larger macro-pores and a higher 
bioactive-glass content, hence a superior bioactivity would be expected from the hybrid 
scaffolds. This is the first study to investigate ceramic-glass hybrids fabricated via honeycomb 
extrusion, and thus further work is needed to determine whether the compressive strength of 
the current hybrid scaffolds can be improved. This will include optimisation of particle size, 
pore geometries and sintering protocol. Furthermore, the scaffolds fabricated herein exhibit 
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only unidirectional interconnected porosity, whereas freeze-casting possesses both longitudinal 
and lateral interconnected pores, and thus will need to be addressed in the future. 
Robocasting is a relatively new approach to forming porous structure. A similar 
principle to extrusion is adopted, whereby a ceramic paste is extruded through a nozzle. The 
nozzle position is pre-determined based on a computer-aided design (CAD), and driven with 
the same principle used in computer numerical controlled machines to fabricate three-
dimensional structures with micrometre resolution5. This spatial resolution allows longitudinal 
and lateral interconnected-pores suitable for BGS to be generated by simply altering the CAD 
model. Interconnected porosity is a limitation of the scaffolds fabricated in the present study, 
as the formation thereof require, for example, porogens, which may increase the complexity of 
the overall fabrication process. Although robocasting is still in its infancy, the results are 
promising, as reported in Table 4. Current drawbacks of the technology are slow speed, high 
capital costs and a high skill-level is required.  
3.3 Cell Viability 
In vitro cell viability revealed the hybrid samples to be biocompatible, as illustrated in Fig. 13. 
The MG63 cell lines were used, which are cell lines originating from human bone, and are 
representative of osteoblastic behaviour. Cell proliferation was observed over a seven-day 
period. This was believed to be as a result of silicon ion dissolution from the substrates, which 
has been found to subsequently induce a genetic response for the bone cells to proliferate, as 
previously discovered66. Gene upregulation occurs within 48 hrs67, which was sustained for 
seven days in the present study, despite comprising only 10 wt% of the total hybrid system. In 
addition, Si dissolution has been found to increase collagen production, which is a component 
of the organic phase of bone, and hence is required for complete bone restoration68.  
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BG1 and BG2 hybrid exhibited the same increasing trend with time, and thus the 
substitution of 5 wt% CaO for Na2O had no effect on the test. It could be contented that a lower 
Na2O content decreases glass solubility, thereby reducing Si dissolution and consequently gene 
upregulation. Although not reported herein, BG2 possessed a higher glass transition 
temperature (Tg) than BG1, which is a prefigure to solubility (i.e. higher Tg equates to a slower 
solubility)69. In addition, previous work had determined that an increase in sodium oxide in 
glass results in an increase to cytotoxicity. Hence, the comparable cell viability results of BG1 
and BG2 may have occurred due to the aforementioned events offsetting one another. Bellucci 
et al. (2013)42, who compared stoichiometric BG to Ca-excess BG, observed an increase in 
MC3T3-E1 cell proliferation over time. Initially the Ca-excess BG yielded the higher cell 
proliferation at day 2, but similar cell proliferation values were observed by day 14. Hence, 
they too established that Ca-excess BG was not detrimental to cells, and comparable cell 
viabilities between stoichiometric and Ca-excess BG.  
In addition to Bellucci et al., only Lopes and Demirkiran from Table 5 examined the 
cell viability of their samples, of which only the latter investigated cell viability at multiple time 
periods. The studies reported no cytotoxicity when BG was added to their respective calcium 
phosphate. Demirkiran et al. (2010)28 investigated the DNA concentration, which correlated to 
the number of bone cells grown, and reported an increase in cell viability with the incorporation 
of 10 wt% glass from day 3 to day 6. Interestingly, incorporating 5 and 25 wt% BG did not 
increase cell viability from day 3 to day 6. The authors attributed it to the various chemical 
compositions obtained post-sintering with each hybrid sample; the 10 wt% composition was 
the only one to exhibit both a ȕ-TCP and an amorphous phase, which may have synergistically 
led to an increase in cell viability. Both ȕ-TCP70, 71 and an amorphous phase72  are known to be 
more soluble than HA, and hence may have resulted in a higher ion dissolution, and 
subsequently a higher rate of cell proliferation and surface roughness73.  
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The CAN hybrid also presented with a similar trend to BG1 and BG2 over seven days. 
Previous work has also illustrated a similar trend over the course of ten days74. At day 7, the 
cell viability was noticeably higher in CAN than either BG, which can be ascribed to fluoride 
ions dissolved therefrom. Fluoride ions are one of the most potent stimulators of bone75. 
Previous work by Lee et al. (2006) reported a higher cell viability in HA-bioactive hybrids 
containing fluorine than fluorine-free hybrids76. The next step would be to investigate the 
biological response in vivo, and determine whether the proliferative behaviour can be translated 
thereto. A previous in vivo study revealed phosphate-free canasite exhibited no 
osteoconductivity, and instead favouring soft tissue binding77. The authors of that study 
postulated that the incorporation of phosphate into the glass network may counteract this.   
 
4  Conclusion 
Hydroxyapatite-bioactive glass scaffolds have been successfully manufactured using 
honeycomb extrusion. Three different samples with varying glass composition were produced. 
The addition of glass induced partial phase transformation of hydroxyapatite to ȕ-tricalcium 
phosphate during sintering. The bulk porosities and compressive strengths ranged from 55 to 
68.6 vol% and 9.8 to 56.7 MPa, respectively, in which increasing the calcium oxide 
concentration of the raw glass improved scaffold strength. All samples supported cell 
proliferation over a seven day period, whereby the highest cell viability was obtained at day 7. 
It is expected that the HA-bioactive glass hybrid scaffolds fabricated via ceramic honeycomb 
extrusion will provide a possible alternative to commercially available bone graft substitutes 
comprised of pure HA or HA and bioactive glass. 
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Tables 
Table 1.  
Glass composition of CAN, BG1 and BG2 in mass%. 
 
Table 2.  
Paste Composition for all hybrid formulations in grams. 
Component Weight (g) 
HA 217 
Bioactive Glass 24 
Methocel® 18 
Distilled Water 100 
 
Table 3.  
Particle Properties of the raw glass powders. 
Sample Particle Size (µm) Powder density 
(g/cm3) 
BET Surface 
area (m2/g) 
 
D10 D50 D90   
BG1 3.24 13.8 27.6 2.75 ± 0.010 3.10 r 0.138 
BG2 1.72 8.81 21.4 2.73 ± 0.002 3.57 r 0.118 
CAN 2.31 16.2 45.1 2.63 r 0.004 2.25 r 0.070 
 
 
Table 4.  
Examples of fabrication techniques that produce aligned porous structures, and their respective 
porosity and compressive strength. (* proprietary glass) 
Technique Material Macro-pore 
size (µm) 
Porosity 
(vol%) 
Compressive 
strength (MPa) 
Ceramic honeycomb 
extrusion46 
HA ~750 45 105.9 
Ceramic co-extrusion61 HA 270 27 240 
Ceramic co-extrusion62 HA ~35 55 19.3 
Freeze-casting64 HA < 600 56 65 
Robocasting78 HA ~300 ~50 140 
Robocasting63, 79 Sr-HT* 
glass 
~900 ~60 139 
Glass Compound CAN mass% BG1 mass% BG2 mass% 
SiO2 58.4 45 45 
P2O5 4.6 6 6 
Na2O 3.7 24.5 19.5 
CaO 15.5 24.5 29.5 
K2O 7.6 - - 
CaF2 10.2 - - 
27 
 
Table 5.  
Examples of calcium phosphate-bioactive glass hybrids, and their respective bioactive glass composition, sintering temperature, dwell time, 
decomposition products and final density relative to pure calcium phosphate. (HA- hydroxyapatite; BG-Bioglass®; TCP- tricalcium phosphate; 
CaSiO ± calcium silicate; Si-HA ± silicon substituted hydroxyapatite) 
Study Starting Hybrid Glass 
mass% 
Sintering (°C) Dwell 
time 
(h) 
Products Density relative to 
pure CaP 
Santos29 HA/BG 5 1200-1300 1 D-TCP,E-TCP, Si-HA Decreased 
Bellucci42 HA/BG_Ca 40 1150 3 HA Decreaseda 
Lopes12 TCP/BG 7.5 1200 2 D-TCP,E-TCP No change 
Goller48 HA/BG 10 1200 & 1300 4 Si-HA, Ca2P2O7, 
Na2HPO4 
N/A 
Yazdanpanah13 HA/Sodalime glass 5 800-1200 2 HA Decreased 
Lin14 CaSiO/BG 5 1100 3 CaSiO Increased 
Knowles15 HA/Na2-CaO-P2O5 2 1200-1350 1 HA No Change 
 
HA/Na2-CaO-P2O5 4 1200-1350 1 D-TCP,E-TCP, HA Decreased 
Tancred16 HA/Phosphate glass 10 1150-1350 3 D-TCP,E-TCP, HA Decreased 
Tancred45 HA/BG 2.5-50 1050-1200 3 E-TCP, HA Decreased 
Demirkiran28 HA/BG 10 1200 4 Si-HA,E-TCP Decreased 
               a
 Relative to a hybrid comprised of HA and stoichiometric BG
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Figures 
Fig. 1. SEM (SE) micrographs representation depictions of the Bioglass (top) and canasite 
(bottom) raw powders. 
Fig. 2. XRD analysis of the raw glass powders. 
Fig. 3. FTIR spectra of the raw powders. 
Fig. 4. STA analysis depicting the DSC (a) and TGA (b) thermograms of the raw bioactive 
glass powders. 
Fig. 5. Images of a sintered CAN extrudate, using an optical (a), SEM (SE) (b) and camera (c). 
Fig. 6. XRD patterns of BG1 and BG2 sintered at different temperatures. 
Fig. 7. XRD pattern of CAN scaffolds sintered at 1250 and 1300 °C. 
Fig. 8. FTIR spectra of BG1 and BG2 at different sintering temperatures. 
Fig. 9. FTIR spectra of HA-CAN sintered at 1250 and 1300 °C. 
Fig. 10. HA-bioactive glass bulk porosities (n = 3) (a) and compressive strength (loading 
performed parallel to cell alignment) (n = 9) (b) values. 
Fig. 11. SEM (SE) micrographs depicting the fracture surface of BG1 (top) and BG2 (bottom), 
at 1200 (left), 1250 (middle) and 1300 °C (right). 
Fig. 12. SEM (SE) micrographs depicting the fracture surface of CAN at 1300 °C. 
Fig. 13. Cell Viability of BG1 and BG2 at 1200 and 1250 °C; CAN at 1300 °C. 
